new byetta drugs coming
Byetta mimics glp-1 a hormone which is produced by nutrition entering the
gut and is involved in insulin production. Usually glp-1 is broken down by
dpp-iv which is always in the body, byetta is resistant to this
breakdown and stays at a higher level longer.
New drugs related to this process are soon to appear. To prevent the
breakdown of glp-1 by suppressing dpp-iv the normal glp-1 can be kept
longer at a higher level. Here is a story about these and a new glp-1
mimic like byetta:
Here is a more detailed and technical look at the new glp-1 mimic:
The dpp-iv drugs are once a day pills and the glp-1 mimic a once a day
injection. They all seem to produce the same positive effects as does
byetta. It will be interesting to see how the market works out in this
area.